SCIENCE
A rare-disease drug reported zero new bone lesions through 84 weeks.
In the OPTIMA extension, adults who stayed on Pasatru had no new lesions detected between weeks 56 and 84; the placebo group had nine.
SOURCERegeneron / The Lancet
—
ALL THE SLOP
Every serving. No expiration date. Page 2 of 3.
SCIENCE
Taiwan reached a 92.7% Hepatitis C treatment rate.
More than 7.86 million people have been screened. Diagnosis reached 92.4%, treatment 92.7%, and treatment in key high-risk groups 95%.
SOURCECommercial Times (Taiwan)
—
SCIENCE
An mRNA vaccine formulation kept working after two months at body-heat temperatures.
A preclinical formulation held onto its biological activity for more than two months at 37°C—and matched fresh material in mouse immune-response tests.
SOURCENature Biotechnology
—
SCIENCE
A phase 3 lung-fibrosis drug preserved breathing better than placebo.
The lower dose met the trial’s main goal over 52 weeks. The higher dose did not, and the detailed results are not yet published.
SOURCEReuters / Bristol Myers Squibb
—
SCIENCE
Latvia’s new alcohol rules were followed by a 27% drop in alcohol-specific deaths.
WHO/Europe calls the result an early signal: the evaluation covers five months and independent peer review is pending.
SOURCEWorld Health Organization Regional Office for Europe
—
SCIENCE
Six people with advanced retinal disease became measurably more sensitive to light.
In a 10-person safety trial, an experimental optogenetic treatment produced clinically meaningful light-sensitivity gains in six participants. It did not restore normal sight.
SOURCENew England Journal of Medicine
—
SCIENCE
A lab-grown lung model kept its own immune memory.
Human lung organoids retained resident T cells, recognized SARS-CoV-2 and responded more strongly after a simulated booster.
SOURCENational Institutes of Health / Nature
—
SCIENCE
A small skin biopsy could spare patients a more invasive test.
Functional testing on skin cells helped close difficult mitochondrial-disease diagnoses across samples from more than 30 medical centres.
SOURCEChildren’s Hospital Colorado / EMBO Molecular Medicine
—
SCIENCE
Bumblebees delivered bacteria-killing viruses to cherry blossoms.
The pollinators carried a precise biological treatment to as many as 88% of flowers.
SOURCEUniversity of Warwick / Biological Control
—
SCIENCE
A knitted crop cover produced 3.56× the harvestable strawberries.
The fabric let light, rain and air through — while keeping insect mouths out.
SOURCENC State News
—
SCIENCE
A paper-thin robot swam through a maze on muscle cells.
Two fins. One layer of living muscle. A light to follow.
SOURCEMIT News
—
SCIENCE
A phone-and-telehealth program cut risky firearm behaviors 57%.
Three remote counseling sessions and a phone tool helped young people make safer decisions in a rigorous trial.
SOURCEUniversity of Michigan Institute for Healthcare Policy and Innovation
—
SCIENCE
A small headset trial found improvements in long-covid brain fog.
Four weeks of at-home magnetic-field sessions produced encouraging early signals for long-COVID cognitive impairment.
SOURCEMount Sinai
—
SCIENCE
A daily pill cut an average liter of volume from swollen legs.
A small trial suggests the first medication for lymphedema may be getting closer.
SOURCEStanford Medicine
—
SCIENCE
They lined the surgery cavity with radioactive tiles. Surgical-site recurrence fell to 1.3%.
A Phase 3 trial turned the walls of a surgical cavity into the radiation treatment.
SOURCEUT MD Anderson Cancer Center / Journal of Clinical Oncology
—
SCIENCE
After brain-metastasis surgery, three to five radiation sessions beat one.
A small scheduling change produced a surprisingly large clinical difference.
SOURCEAmerican Society for Radiation Oncology
—
SCIENCE
A urine-and-swab test ruled out womb cancer 98.8% of the time.
A painless test using urine and a vaginal swab showed it could accurately rule out womb cancer for most women with postmenopausal bleeding.
SOURCEUniversity of Manchester
—
SCIENCE
A vitamin-derived molecule reached its target in mitochondrial disease patients.
A Cambridge-led study gave nicotinamide riboside to eight people with mitochondrial DNA disease. It was well tolerated and showed early signs of working.
SOURCEGenome Medicine / University of Cambridge
—
SCIENCE
An experimental drug gave mice with MS-like disease their movement back.
In a mouse model of multiple sclerosis, the experimental drug K-9 restored function after paralysis and vision loss had already set in. It has not been tested in people with MS.
SOURCENational Institutes of Health / UVA Health
—
SCIENCE
Chagas treatment just got cut from 60 days to 30.
In the TESEO trial, 450 adults received different benznidazole regimens. The 30-day, once-daily option matched the standard 60-day course in the trial and caused fewer side effects.
SOURCEUTEP
—
SCIENCE
THE SCAN CAME BACK EMPTY.
SCIENCE
Two doses of a new immunotherapy cleared a child's liver cancer.
Researchers at Texas Children's, Baylor College of Medicine and Seattle Children's reported in the New England Journal of Medicine that a child with hepatoblastoma had complete regression of disease after a novel immunotherapy given as part of the CARE study.
SOURCETexas Children's Hospital
—
SCIENCE
THE HAND FELT BACK.
SCIENCE
He lost his arm at 16. Now he can feel his wife's hand.
Seventeen years after an amputation, Alexander “Avi” Davidson became the first participant to take Utah's thought-controlled bionic arm home — with a nerve interface that gives it a sense of touch.
SOURCEUniversity of Utah Health
—
SCIENCE
TWO ORIGINS. ONE BRAIN.
SCIENCE
The human brain may have been built from two ancient systems.
Stanford researchers found the forebrain/midbrain and hindbrain arise from distinct progenitor cell populations — and used that insight to grow functional human hindbrain motor neurons in the lab.
SOURCEStanford Medicine
—
SCIENCE
THE GENOME GOT A BIGGER TOOLBOX.
SCIENCE
Gene editing just learned to move bigger pieces of DNA.
A new lab method can place gene-sized DNA at targeted sites in human cells. No patients yet.
SOURCENature
—